Literature DB >> 3538137

Detection of multivessel disease after myocardial infarction using intravenous stress digital subtraction angiography.

G R Bellamy, J Yiannikas, R Detrano, C Simpfendorfer, E E Salcedo.   

Abstract

Forty-six patients with prior myocardial infarction underwent stress intravenous digital subtraction angiography (DSA) and coronary angiography. The left ventricular ejection fraction (EF) and wall-motion responses to exercise were correlated with the coronary anatomy. Twenty-five patients with single vessel disease showed essentially no change in left ventricular EF with exercise (a decrease from 66% to 64%), but those with multivessel disease (21 patients) had a significant decrease in left ventricular EF (from 59% to 48%) (P = .0001). A decrease in left ventricular EF had a sensitivity of 95% and specificity of 60% for the detection of multivessel disease, whereas an increase in wall-motion abnormality had a sensitivity and specificity of 72% and 71%, respectively. After myocardial infarction, a fall in left ventricular EF with stress intravenous DSA is highly sensitive for the detection of multivessel disease, but there are a number of false-positive results, resulting in only moderate specificity. A new wall motion abnormality has only a moderate sensitivity and specificity.

Entities:  

Mesh:

Year:  1986        PMID: 3538137     DOI: 10.1148/radiology.161.3.3538137

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Development of digital subtraction angiography for coronary artery.

Authors:  Megumi Yamamoto; Yasuhiko Okura; Masaharu Ishihara; Masayuki Kagemoto; Kengo Harada; Takayuki Ishida
Journal:  J Digit Imaging       Date:  2008-03-20       Impact factor: 4.056

2.  Digital coronary angiography: the new gold standard?

Authors:  G Hartnell; P Wilde
Journal:  Br Heart J       Date:  1991-09

Review 3.  Myocardial scintigraphy--25 years after start.

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.